The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489

Cell Death

Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477

The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection

Hu, H., Tian, M., Ding, C., & Yu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03083 · Cited by 1,177

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

Hata, A. N., Niederst, M. J., Archibald, H. L., Gomez-Caraballo, M., Siddiqui, F. M., Mulvey, H. E., Maruvka, Y. E., Ji, F., Bhang, H.-E. C., Krishnamurthy Radhakrishna, V., et al. (2016) · Nature Medicine · doi:10.1038/nm.4040 · Cited by 985

Tumor biomarkers for diagnosis, prognosis and targeted therapy

Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 836

Precision medicine for cancer with next-generation functional diagnostics

Friedman, A. A., Letai, A., Fisher, D. E., & Flaherty, K. T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4015 · Cited by 570

Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer

Liu, G., Pei, F., Yang, F., Li, L., Amin, A. D., Liu, S., Buchan, J. R., & Cho, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020367 · Cited by 430

Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy

Chen, W., Dong, J., Haiech, J., Kilhoffer, M., & Zeniou, M. (2016) · Stem Cells International · doi:10.1155/2016/1740936 · Cited by 422

The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

Nechiporuk, T., Kurtz, S. E., Nikolova, O. H., Liu, T., Jones, C. L., D’Alessandro, A., Culp‐Hill, R., d’Almeida, A., Joshi, S. K., Rosenberg, M. W., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0125 · Cited by 392

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

Pan, R., Ruvolo, V., Mu, H., Leverson, J. D., Nichols, G., Reed, J. C., Konopleva, M., & Andreeff, M. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.003 · Cited by 300

N6-methyladenosine methyltransferases: functions, regulation, and clinical potential

Huang, W., Chen, T.-Q., Fang, K., Zeng, Z., Ye, H., & Chen, Y.-Q. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01129-8 · Cited by 281

Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death

Lu, H., Zhang, S., Wu, J., Chen, M., Cai, M., Fu, Y., Li, W., Wang, J., Zhao, X., Yu, Z., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1478 · Cited by 272

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Verissimo, C. S., Overmeer, R. M., Ponsioen, B., Drost, J., Mertens, S., Verlaan-Klink, I., Gerwen, B. V., van der Ven, M., Wetering, M. V. D., Egan, D. A., et al. (2016) · eLife · doi:10.7554/elife.18489 · Cited by 263

The Odyssey of Bioactive Compounds in Avocado (Persea americana) and Their Health Benefits

Bhuyan, D. J., Alsherbiny, M. A., Perera, Low, M., Basu, A., Devi, O. A., Barooah, M. S., Li, C. G., & Papoutsis, K. (2019) · Antioxidants · doi:10.3390/antiox8100426 · Cited by 260

Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer

Adachi, Y., Ito, K., Hayashi, Y., Kimura, R., Tan, T. Z., Yamaguchi, R., & Ebi, H. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2077 · Cited by 249

Role of the PI3K/AKT (mTOR and GSK3β) signalling pathway and photobiomodulation in diabetic wound healing

Jere, S. W., Houreld, N. N., & Abrahamse, H. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.03.001 · Cited by 257

Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis

Pan, R. A., Ryan, J. A., Pan, D., Wucherpfennig, K. W., & Letai, A. G. (2022) · Cell · doi:10.1016/j.cell.2022.03.030 · Cited by 204

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer

López, A., Reyna, D. E., Gitego, N., Kopp, F., Zhou, H., Miranda-Román, M. A., Nordstrøm, L. U., Narayanagari, S.-R., Chi, P., Vilar, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28741-7 · Cited by 203

Mechanisms of Taxane Resistance

Maloney, S., Spring, C., Morejon-Lasso, L., & Prosperi, J. (2020) · Cancers · doi:10.3390/cancers12113323 · Cited by 198

Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer

Cabanos, H. F., & Hata, A. N. (2021) · Cancers · doi:10.3390/cancers13112666 · Cited by 189

STAT3 and apoptosis challenges in cancer

Fathi, N., Rashidi, G., Khodadadi, A., Shahi, S., & Sharifi, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.121 · Cited by 191

Mitochondrial quality control as a key determinant of cell survival

Sedlackova, L., & Korolchuk, V. I. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.12.012 · Cited by 187

Apoptosis in Cancer Biology and Therapy

Moyer, A. F., Tanaka, K., & Cheng, E. H. Y. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-115023 · Cited by 212

Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy

Rosenbaum, S. R., Wilski, N. A., & Aplin, A. E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0805 · Cited by 177

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells

Carter, B. Z., Mak, P. Y., Mu, H., Zhou, H., Mak, D. H. F., Schober, W. D., Leverson, J. D., Zhang, B., Bhatia, R., Huang, X., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1180 · Cited by 175

Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis

Tanaka, K., Yu, H. A., Yang, S., Han, S., Selçuklu, S. D., Kim, K., Ramani, S., Ganesan, Y. T., Moyer, A. F., Sinha, S., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.006 · Cited by 169

Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia

Reyna, D. E., Garner, T. P., López, A., Kopp, F., Choudhary, G. S., Sridharan, A., Narayanagari, S.-R., Mitchell, K., Dong, B., Bartholdy, B., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.001 · Cited by 164

Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer

Mérino, D., Lok, S. W., Visvader, J. E., & Lindeman, G. J. (2015) · Oncogene · doi:10.1038/onc.2015.287 · Cited by 164

FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation

Tong, J., Tan, S., Zou, F., Yu, J., & Zhang, L. (2016) · Oncogene · doi:10.1038/onc.2016.247 · Cited by 163

Inhibitors of apoptosis: clinical implications in cancer

Mohamed, M. S., Bishr, M. K., Almutairi, F. M., & Ali, A. G. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1429-4 · Cited by 162

Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer

D’Aguanno, S., & Bufalo, D. D. (2020) · Cells · doi:10.3390/cells9051287 · Cited by 158

Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors

Zhang, S., Zhang, M., Jing, Y., Yin, X., Ma, P., Zhang, Z., Wang, X., Di, W. J., & Zhuang, G. (2018) · Nature Communications · doi:10.1038/s41467-017-02693-9 · Cited by 150

Citrus Peel Flavonoids as Potential Cancer Prevention Agents

Koolaji, N., Shammugasamy, B., Schindeler, A., Dong, Q., Dehghani, F., & Valtchev, P. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa025 · Cited by 142

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

Marchandet, L., Lallier, M., Charrier, C., Baud’huin, M., Ory, B., & Lamoureux, F. (2021) · Cancers · doi:10.3390/cancers13040683 · Cited by 142

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Zelenetz, A. D., Salles, G. A., Mason, K. D., Casulo, C., Gouill, S. L., Sehn, L. H., Tilly, H., Cartron, G., Chamuleau, M. E. D., Goy, A. H., et al. (2019) · Blood · doi:10.1182/blood-2018-11-880526 · Cited by 139

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

Ham, J., Costa, C., Sano, R., Lochmann, T. L., Sennott, E. M., Patel, N. U., Dastur, A., Gomez‐Caraballo, M., Krytska, K., Hata, A. N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.002 · Cited by 135

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence

Darici, S., Alkhaldi, H., Horne, G. A., Jørgensen, H. G., Marmiroli, S., & Huang, X. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092934 · Cited by 135

Structural characterization of a novel neutral polysaccharide from Lentinus giganteus and its antitumor activity through inducing apoptosis

Tian, Y., Zhao, Y., Zeng, H., Zhang, Y., & Zheng, B. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.08.059 · Cited by 127

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma

Khan, Z., Khan, A. A., Yadav, H., Prasad, G. B. K. S., & Bisen, P. S. (2017) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-017-0038-0 · Cited by 117

Failed Apoptosis Enhances Melanoma Cancer Cell Aggressiveness

Berthenet, K., Ferrer, C. C., Fanfone, D., Popgeorgiev, N., Neves, D., Bertolino, P., Gibert, B., Hernández‐Vargas, H., & Ichim, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107731 · Cited by 120

Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting

Bisht, S., Nigam, M., Kunjwal, S. S., Plygun, S., Mishra, A. P., & Sharifi‐Rad, J. (2022) · Stem Cells International · doi:10.1155/2022/9653244 · Cited by 113

Mfn2 Regulates High Glucose-Induced MAMs Dysfunction and Apoptosis in Podocytes via PERK Pathway

Cao, Y., Chen, Z., Hu, J., Feng, J., Zhu, Z., Fan, Y., Lin, Q., & Ding, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.769213 · Cited by 113

Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin–AKT Signaling Pathway in Lung Cancer

Wang, M., Zhang, G., Zhang, Y., Cui, X., Wang, S., Gao, S., Wang, Y., Liu, Y., Bae, J. H., Yang, W., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1033 · Cited by 108

Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology

Choudhury, H., Pandey, M., Yin, T. H., Kaur, T., Jia, G. W., Tan, S. Q. L., Weijie, H., Yang, E. K. S., Keat, C. G., Bhattamisra, S. K., et al. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.04.005 · Cited by 108

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

Wu, Q., Zhen, Y., Shi, L., Vu, P., Greninger, P., Adil, R., Merritt, J., Egan, R., Wu, M.-J., Yin, X., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1168 · Cited by 104

Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma

Lochmann, T. L., Powell, K. M., Ham, J., Floros, K. V., Heisey, D. A. R., Kurupi, R., Calbert, M. L., Ghotra, M. S., Greninger, P., Dozmorov, M. G., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4680 · Cited by 103

MYC and therapy resistance in cancer: risks and opportunities

Donati, G., & Amati, B. B. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13319 · Cited by 104

Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context

Saddam, M., Paul, S. K., Habib, M. A., Fahim, M. A., Mimi, A. A., Islam, S., Paul, B., & Helal, M. M. U. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00485-7 · Cited by 110

Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression

Wang, X., Qin, X., Yan, M., Shi, J., Xu, Q., Li, Z., Yang, W., Zhang, J., & Chen, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1144-9 · Cited by 99

Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic

Emdad, L., Bhoopathi, P., Talukdar, S., Pradhan, A. K., Sarkar, D., Wang, X., Das, S. K., & Fisher, P. B. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.013 · Cited by 96

Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM

Song, K.-A., Niederst, M. J., Lochmann, T. L., Hata, A. N., Kitai, H., Ham, J., Floros, K. V., Hicks, M. A., Hu, H., Mulvey, H. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1577 · Cited by 95

Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS -Mutant Non–Small Cell Lung Cancer

Nangia, V., Siddiqui, F. M., Caenepeel, S., Timonina, D., Bilton, S. J., Phan, N., Gomez-Caraballo, M., Archibald, H. L., Li, C., Fraser, C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0277 · Cited by 94

A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma

Ilyas, S. I., Yamada, D., Hirsova, P., Bronk, S. F., Werneburg, N. W., Krishnan, A., Salim, W., Zhang, L. N., Trushina, E. V., Truty, M. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698472 · Cited by 94

Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas

Pham, L. V., Huang, S., Zhang, H., Zhang, J., Bell, T., Zhou, S., Pogue, E., Ding, Z., Lam, L. T., Westin, J. R., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3004 · Cited by 94

Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines

An, W., Lai, H., Zhang, Y., Liu, M., Lin, X., & Cao, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00758 · Cited by 93

Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer

Ho, C. J., & Gorski, S. M. (2019) · Cancers · doi:10.3390/cancers11111775 · Cited by 93

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Jiang, L., Zhang, H.-D., & Tang, J.-H. (2018) · Journal of Oncology · doi:10.1155/2018/5167829 · Cited by 91

BH3-only protein BIM: An emerging target in chemotherapy

Shukla, S., Saxena, S., Singh, B. K., & Kakkar, P. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.09.002 · Cited by 87

Structure elucidation and antitumor activity of a water soluble polysaccharide from Hemicentrotus pulcherrimus

Jiang, Y., Shang, Z., Lv, X., Du, M., Li, M., Hou, G., Chen, J., Wang, C., & Zhao, F. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119718 · Cited by 88

Targeting apoptosis in acute myeloid leukaemia

Cassier, P. A., Castets, M., Belhabri, A., & Vey, N. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.281 · Cited by 86

Anticancer effects of bifidobacteria on colon cancer cell lines

Faghfoori, Z., Faghfoori, M. H., Saber, A., Izadi, A., & Khosroushahi, A. Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01971-3 · Cited by 85

Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation

Titus, S., Szymańska, K. J., Musul, B., Turan, V., Taylan, E., García-Milian, R., Mehta, S., & Oktay, K. (2021) · Scientific Reports · doi:10.1038/s41598-020-79643-x · Cited by 83

SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers

Jones, G. G., del Río, I. B., Sarı, S., Sekerim, A., Young, L. C., Hartig, N., Zubiaur, I. A., El-Bahrawy, M. A., Hynds, R. E., Lei, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10367-x · Cited by 77

KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer

Zhang, H., Ma, R.-R., Wang, X.-J., Su, Z.-X., Chen, X.-L., Shi, D.-B., Guo, X.-Y., Liu, H.-T., & Gao, P. (2017) · Oncogene · doi:10.1038/onc.2017.163 · Cited by 77

The IGF-1 Signaling Pathway in Viral Infections

Józefiak, A., Larska, M., Pomorska‐Mól, M., & Ruszkowski, J. J. (2021) · Viruses · doi:10.3390/v13081488 · Cited by 76

Annurca apple polyphenol extract selectively kills MDA-MB-231 cells through ROS generation, sustained JNK activation and cell growth and survival inhibition

Martino, E., Vuoso, D. C., D’Angelo, S., Mele, L. L., D’Onofrio, N., Porcelli, M., & Cacciapuoti, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-49631-x · Cited by 75

Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles

Samuel, P., Fabbri, M., & Carter, D. R. F. (2017) · PROTEOMICS · doi:10.1002/pmic.201600375 · Cited by 74

Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy

Ma, B., Yuan, Z., Zhang, L., Lv, P., Yang, T., Gao, J., Pan, N., Wu, Q., Lou, J., Han, C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.008 · Cited by 73

Natural Agents Targeting Mitochondria in Cancer

Mani, S., Swargiary, G., & Singh, K. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196992 · Cited by 76

Structural characterization and antitumor activity of a novel Se-polysaccharide from selenium-enriched Cordyceps gunnii

Sun, H.-Q., Zhu, Z., Tang, Y., Ren, Y., Song, Q., Tang, Y., & Zhang, Y. (2018) · Food & Function · doi:10.1039/c8fo00027a · Cited by 72

MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway

Wu, H., Liu, Y.-E., Hsu, K., Wang, Y., Chan, Y.-C., Chen, Y., & Chen, D. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500603 · Cited by 70

Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance

Kim, J., Shim, M. K., Yang, S., Moon, Y., Song, S., Choi, J., Kim, J., & Kim, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.065 · Cited by 70

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Peirs, S., Frismantas, V., Matthijssens, F., Loocke, W. V., Pieters, T., Vandamme, N., Lintermans, B., Dobay, M. P., Berx, G., Poppe, B. G., et al. (2017) · Leukemia · doi:10.1038/leu.2017.10 · Cited by 71

RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment

Hein, A. L., Post, C. M., Sheinin, Y. M., Lakshmanan, I., Natarajan, A., Enke, C. A., Batra, S. K., Ouellette, M. M., & Yan, Y. (2016) · Oncogene · doi:10.1038/onc.2016.163 · Cited by 69

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition

Facchinetti, F., Rossi, G., Bria, E., Soria, J., Besse, B., Minari, R., Friboulet, L., & Tiseo, M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.02.010 · Cited by 69

Drug and apoptosis resistance in cancer stem cells (CSCs): A puzzle with many pieces

Safa, A. R. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.20 · Cited by 71

Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis

Zhang, B., Lai, Y., Li, Y., Shu, N., Wang, Z., Wang, Y., Li, Y., & Chen, Z. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.053 · Cited by 69

Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma

He, C., Liu, C., Wang, L., Sun, Y., Jiang, Y., & Hao, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1347-1 · Cited by 66

Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3

Park, W. Y., Song, G., Park, J. Y., Ahn, K. S., Kwak, H. J., Park, J., Lee, J., & Um, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04995-3 · Cited by 67

Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma

Yang, F., Shi, L., Liang, T., Ji, L., Zhang, G., Shen, Y., Zhu, F., & Xu, L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.017 · Cited by 67

A cold-water soluble polysaccharide isolated from Grifola frondosa induces the apoptosis of HepG2 cells through mitochondrial passway

Chen, P., Liu, H., Ji, H.-H., Sun, N., & Feng, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.098 · Cited by 67

miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression

Xu, X., Jin, S., Ma, Y., Fan, Z., Yan, Z., Li, W., Song, Q., You, W., Lyu, Z., Song, Y., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1539-z · Cited by 66

Increased Synthesis of MCL-1 Protein Underlies Initial Survival of EGFR -Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target

Song, K.-A., Hosono, Y., Turner, C., Jacob, S., Lochmann, T. L., Murakami, Y., Patel, N. U., Ham, J., Hu, B., Powell, K. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0304 · Cited by 67

Cells, drugs and NMR

Siegal, G., & Selenko, P. (2019) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2019.07.018 · Cited by 67

Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies

Yan, X., Chen, D., Wang, Y., Guo, Y., Tong, C., Wei, J., Zhang, Y., Wu, Z., & Han, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00915-1 · Cited by 65

Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells

Thangaraj, K., Balasubramanian, B., Park, S., Natesan, K., Liu, W., & Vaiyapuri, M. (2019) · Biomolecules · doi:10.3390/biom9090418 · Cited by 64

Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate

Li, Y., Zhou, Y., Liu, D., Wang, Z., Qiu, J., Zhang, J., Chen, P., Zeng, G., Guo, Y., Wang, X., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04432-9 · Cited by 65

Structural characterization of a low molecular weight polysaccharide from Grifola frondosa and its antitumor activity in H22 tumor-bearing mice

Ji, H., Yu, J., & Liu, A.-J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103472 · Cited by 61

Antitumor mechanisms of an exopolysaccharide from Lactobacillus fermentum on HT-29 cells and HT-29 tumor-bearing mice

Li, F., Jiao, X., Zhao, J., Liao, X., Wei, Y., & Li, Q. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.023 · Cited by 60

Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins

de Araujo, A. D., Lim, J., Wu, K., Xiang, Y., Good, A. C., Skerlj, R. T., & Fairlie, D. P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00010 · Cited by 61

Purification of an acidic polysaccharide from Suaeda salsa plant and its anti-tumor activity by activating mitochondrial pathway in MCF-7 cells

Liu, X., Liu, F., Zhao, S., Guo, B., Ling, P., Han, G., & Cui, Z. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.03.059 · Cited by 60

The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism

Zaanan, A., Okamoto, K., Kawakami, H., Khazaie, K., Huang, S., & Sinicrope, F. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657833 · Cited by 59

Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr)

Karanam, G., & Arumugam, M. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05407-5 · Cited by 61

Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies

Razaghi, A., Heimann, K., Schaeffer, P. M., & Gibson, S. B. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1440-4 · Cited by 60

Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer

Polanco, E. R., Moustafa, T. E., Butterfield, A., Scherer, S. D., Cortes-Sanchez, E., Bodily, T. A., Spike, B. T., Welm, B. E., Bernard, P. S., & Zangle, T. A. (2022) · Communications Biology · doi:10.1038/s42003-022-03759-1 · Cited by 56

Competing endogenous RNAs in lung cancer

Zhao, M., Feng, J., & Tang, L. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0203 · Cited by 61

Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL

Nayak, D., Lv, D., Yuan, Y., Zhang, P., Hu, W., Nayak, A., Ruben, E. A., Lv, Z., Sung, P., Hromas, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46922-4 · Cited by 61

Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf

Dzobo, K., Senthebane, D. A., Rowe, A., Thomford, N. E., Mwapagha, L. M., Al-Awwad, N., Dandara, C., & Parker, M. I. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0152 · Cited by 58

Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma

Wang, R., Deng, D., Shao, N., Xu, Y., Xue, L., Peng, Y., Liu, Y., & Zhi, F. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s155275 · Cited by 59

A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior

Monferrer, E., Martín-Vañó, S., Carretero, A., García‐Lizarribar, A., Burgos‐Panadero, R., Navarro, S., Samitier, J., & Noguera, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-62986-w · Cited by 58

Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer

Yang, H., Wei, B., & Hu, B. (2021) · Inflammation Research · doi:10.1007/s00011-021-01501-x · Cited by 56

In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models

Hughes, P. E., Rex, K. L., Caenepeel, S. R., Yang, Y., Zhang, Y., Broome, M. A., Kha, H. T., Burgess, T. L., Amore, B. M., Kaplan‐Lefko, P. J., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0871 · Cited by 56

The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.985363 · Cited by 1,011

Targeting BCL-2 regulated apoptosis in cancer

Campbell, K. J., & Tait, S. W. G. (2018) · Open Biology · doi:10.1098/rsob.180002 · Cited by 564

Biomarkers of Therapeutic Response to BCL2 Antagonists in Cancer

Lam, L. T., Zhang, H., & Chyla, B. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-012-0003-6 · Cited by 13

Cell Death and Targeted Cancer Therapies

(2022) · Frontiers research topics · doi:10.3389/978-2-88976-684-0

Diagnosing and exploiting cancer's addiction to blocks in apoptosis

Letai, A. G. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2297 · Cited by 590